The National Cancer Institute (NCI) is offering this U01 revision grant to accelerate cancer research by integrating novel technologies. This grant is for currently funded NCI U01 research projects. Applicants should propose expanding their original research questions or accelerating progress by incorporating a new technical approach or instrument developed through the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this opportunity aim to incentivize the independent validation and rapid adoption of these emerging technologies within appropriate research communities. As a key component of the NCI IMAT program, this initiative also seeks to promote vital interdisciplinary collaboration in developing innovative tools and methods crucial for advancing cancer research and accelerating scientific discovery.
Opportunity ID: 337195
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-CA-22-006 |
Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Jan 04, 2022 |
Last Updated Date: | Jan 04, 2022 |
Original Closing Date for Applications: | Sep 22, 2022 |
Current Closing Date for Applications: | Sep 22, 2022 |
Archive Date: | Oct 28, 2022 |
Estimated Total Program Funding: | – |
Award Ceiling: | $150,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Independent school districts Private institutions of higher education County governments City or township governments Special district governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI U01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-006.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
Folder 337195 Full Announcement-RFA-CA-22-006 -> RFA-CA-22-006-Full-Announcement.pdf
Packages
Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or after January 25, 2022 | PKG00271218 | Mar 22, 2022 | Sep 22, 2022 | View |
Package 1
Mandatory forms
337195 RR_SF424_5_0-5.0.pdf
337195 PHS398_CoverPageSupplement_5_0-5.0.pdf
337195 RR_OtherProjectInfo_1_4-1.4.pdf
337195 PerformanceSite_4_0-4.0.pdf
337195 RR_KeyPersonExpanded_4_0-4.0.pdf
337195 PHS398_ResearchPlan_4_0-4.0.pdf
337195 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337195 RR_Budget_3_0-3.0.pdf
337195 RR_SubawardBudget30_3_0-3.0.pdf
337195 PHS398_ModularBudget_1_2-1.2.pdf
337195 PHS_AssignmentRequestForm_3_0-3.0.pdf